Follow-up typically starts every 2 to 4 weeks during initiation, then extends to every 3 to 6 months once stable
however, the study suggests that children under 12 may also benefit from their use
A possible mechanism: GLP-1s appear to dampen dopamine-mediated reward responses , which may be helpful for cravings, but could also blunt some forms of desire, including sexual
At RevIVe Mobile IV Therapy, we bring physician-led care directly to your doorstep, administered by experienced ER nurses who understand both the science and the art of making you feel comfortable and cared for
(PubMed) Rinella ME, Lazarus JV, Ratziu V, et al
Patients carrying specific genetic variants may experience stronger appetite suppression at lower doses, potentially reducing the need to escalate toward the 2.4 mg maximum